TY - JOUR
T1 - Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis
AU - Wculek, Stefanie K.
AU - Heras-Murillo, Ignacio
AU - Mastrangelo, Annalaura
AU - Mañanes, Diego
AU - Galán, Miguel
AU - Miguel, Verónica
AU - Curtabbi, Andrea
AU - Barbas, Coral
AU - Chandel, Navdeep S.
AU - Enríquez, José Antonio
AU - Lamas, Santiago
AU - Sancho, David
N1 - Funding Information:
We are grateful to N.-G. Larsson, F. Sánchez-Madrid, G. Sabio, R.D. Palmiter, E. Gottlieb, C.T. Moraes, and M.A. del Pozo for sharing essential reagents. We thank S. Iborra, his team, M. Sánchez-Álvarez, I. Nikolic, and members of the D.S. laboratory for discussions and critical reading of the manuscript. We thank the staff at the CNIC technical units; foremost the animal, cellomics, histology, metabolomics, genomics, microscopy, and bioinformatics facilities; and the SIdI of the Universidad Autónoma de Madrid for technical support. This project was supported by the “la Caixa” Foundation (ID 100010434) Postdoctoral Junior Leader Fellowship code LCF/BQ/PR20/11770008 (S.K.W.); “la Caixa” Foundation (ID 100010434) INPhINIT Fellowship code LCF/BQ/IN17/11620074 (I.H.-M.); Spanish Ministry of Education FPU fellowship code FPU20/01418 (M.G.); Ministerio de Ciencia e Innovación (MCIN) PID2019-104233RB-100/AEI/10.13039/501100011033 (S.L.); and NIH grants P01AG049665-08, RO1A148190, and P01HL154998 (N.S.C.). The J.A.E. laboratory is supported by the CNIC and a grant by Ministerio de Ciencia, Innovación y Universidades (MCNU); Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) (RTI2018-099357-B-I00); the Biomedical Research Networking Center on Frailty and Healthy Ageing (CIBERFES-ISCiii-CB16/10/00289); and the HFSP agency (RGP0016/2018). Work in the D.S. laboratory is funded by the CNIC; by the European Union's Horizon 2020 research and innovation program under grant agreement ERC-2016-Consolidator grant 725091; by Spanish Ministerio de Ciencia e Innovación PID2019-108157RB/AEI/ and CPP2021-008310/AEI/10.13039/501100011033; by Comunidad de Madrid (P2022/BMD-7333 INMUNOVAR-CM); and by “la Caixa” Foundation (LCF/PR/HR20/00075 and LCF/PR/HR22/00253). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICINN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (CEX2020-001041-S funded by MCIN/AEI/10.13039/501100011033). Conceptualization, S.K.W. I.H.-M. and D.S.; methodology, investigation, analysis, visualization, and validation, S.K.W. I.H.-M. A.M. D.M. M.G. S.L. V.M. and A.C.; essential reagents and support, C.B. J.A.E. and N.S.C.; writing of original draft, S.K.W. and D.S.; funding acquisition, supervision, and project administration, S.K.W. and D.S.; editing of draft, all authors. The authors declare no competing interests.
Funding Information:
We are grateful to N.-G. Larsson, F. Sánchez-Madrid, G. Sabio, R.D. Palmiter, E. Gottlieb, C.T. Moraes, and M.A. del Pozo for sharing essential reagents. We thank S. Iborra, his team, M. Sánchez-Álvarez, I. Nikolic, and members of the D.S. laboratory for discussions and critical reading of the manuscript. We thank the staff at the CNIC technical units; foremost the animal, cellomics, histology, metabolomics, genomics, microscopy, and bioinformatics facilities; and the SIdI of the Universidad Autónoma de Madrid for technical support. This project was supported by the “la Caixa” Foundation (ID 100010434 ) Postdoctoral Junior Leader Fellowship code LCF/BQ/PR20/11770008 (S.K.W.); “la Caixa” Foundation (ID 100010434 ) INPhINIT Fellowship code LCF/BQ/IN17/11620074 (I.H.-M.); Spanish Ministry of Education FPU fellowship code FPU20/01418 (M.G.); Ministerio de Ciencia e Innovación (MCIN) PID2019-104233RB-100/AEI /10.13039/501100011033 (S.L.); and NIH grants P01AG049665-08 , RO1A148190 , and P01HL154998 (N.S.C.). The J.A.E. laboratory is supported by the CNIC and a grant by Ministerio de Ciencia, Innovación y Universidades (MCNU); Agencia Estatal de Investigación (AEI) and Fondo Europeo de Desarrollo Regional (FEDER) ( RTI2018-099357-B-I00 ); the Biomedical Research Networking Center on Frailty and Healthy Ageing ( CIBERFES-ISCiii-CB16/10/00289 ); and the HFSP agency ( RGP0016/2018 ). Work in the D.S. laboratory is funded by the CNIC ; by the European Union’s Horizon 2020 research and innovation program under grant agreement ERC-2016-Consolidator grant 725091; by Spanish Ministerio de Ciencia e Innovación PID2019-108157RB/AEI / and CPP2021-008310/AEI /10.13039/501100011033; by Comunidad de Madrid ( P2022/BMD-7333 INMUNOVAR-CM); and by “la Caixa” Foundation ( LCF/PR/HR20/00075 and LCF/PR/HR22/00253 ). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the MICINN, and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence ( CEX2020-001041-S funded by MCIN/AEI /10.13039/501100011033).
Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2023/3/14
Y1 - 2023/3/14
N2 - In vitro studies have associated oxidative phosphorylation (OXPHOS) with anti-inflammatory macrophages, whereas pro-inflammatory macrophages rely on glycolysis. However, the metabolic needs of macrophages in tissues (TMFs) to fulfill their homeostatic activities are incompletely understood. Here, we identified OXPHOS as the highest discriminating process among TMFs from different organs in homeostasis by analysis of RNA-seq data in both humans and mice. Impairing OXPHOS in TMFs via Tfam deletion differentially affected TMF populations. Tfam deletion resulted in reduction of alveolar macrophages (AMs) due to impaired lipid-handling capacity, leading to increased cholesterol content and cellular stress, causing cell-cycle arrest in vivo. In obesity, Tfam depletion selectively ablated pro-inflammatory lipid-handling white adipose tissue macrophages (WAT-MFs), thus preventing insulin resistance and hepatosteatosis. Hence, OXPHOS, rather than glycolysis, distinguishes TMF populations and is critical for the maintenance of TMFs with a high lipid-handling activity, including pro-inflammatory WAT-MFs. This could provide a selective therapeutic targeting tool.
AB - In vitro studies have associated oxidative phosphorylation (OXPHOS) with anti-inflammatory macrophages, whereas pro-inflammatory macrophages rely on glycolysis. However, the metabolic needs of macrophages in tissues (TMFs) to fulfill their homeostatic activities are incompletely understood. Here, we identified OXPHOS as the highest discriminating process among TMFs from different organs in homeostasis by analysis of RNA-seq data in both humans and mice. Impairing OXPHOS in TMFs via Tfam deletion differentially affected TMF populations. Tfam deletion resulted in reduction of alveolar macrophages (AMs) due to impaired lipid-handling capacity, leading to increased cholesterol content and cellular stress, causing cell-cycle arrest in vivo. In obesity, Tfam depletion selectively ablated pro-inflammatory lipid-handling white adipose tissue macrophages (WAT-MFs), thus preventing insulin resistance and hepatosteatosis. Hence, OXPHOS, rather than glycolysis, distinguishes TMF populations and is critical for the maintenance of TMFs with a high lipid-handling activity, including pro-inflammatory WAT-MFs. This could provide a selective therapeutic targeting tool.
KW - cholesterol handling
KW - immunometabolism
KW - obesity
KW - oxidative phosphorylation
KW - pro-inflammatory macrophages
KW - Tfam
KW - tissue macrophages
UR - http://www.scopus.com/inward/record.url?scp=85149929602&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85149929602&partnerID=8YFLogxK
U2 - 10.1016/j.immuni.2023.01.011
DO - 10.1016/j.immuni.2023.01.011
M3 - Article
C2 - 36738738
AN - SCOPUS:85149929602
SN - 1074-7613
VL - 56
SP - 516-530.e9
JO - Immunity
JF - Immunity
IS - 3
ER -